Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wonshik Han

Showing results (281-290 of 384) with videos related to

Pageof 39
Sort By:
Oncotarget|September 3, 2016
Accelerated whole breast irradiation in early breast cancer patients with adverse prognostic featuresSea-Won Lee, Kyung Hwan Shin, Eui Kyu Chie, et al.
Scientific Reports|April 20, 2021
Analysis of BRCA1/2 variants of unknown significance in the prospective Korean Hereditary Breast Cancer studyJoo Heung Kim, Sunggyun Park, Hyung Seok Park, et al.
Molecular Cancer Research : MCR|October 18, 2012
STAT3-RANTES autocrine signaling is essential for tamoxifen resistance in human breast cancer cellsEun Hee Yi, Chang Seok Lee, Jin-Ku Lee, et al.
BMC Cancer|April 14, 2007
Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapyKyung-Hun Lee, Seock-Ah Im, Do-Youn Oh, et al.
Journal of Breast Cancer|April 7, 2017
Genetic Predisposition of Polymorphisms in <i>HMGB1</i>-Related Genes to Breast Cancer Prognosis in Korean WomenJunsu Lee, Jaesung Choi, Seokang Chung, et al.
Oncogene|April 30, 2022
Reduced miR-371b-5p expression drives tumor progression via CSDE1/RAC1 regulation in triple-negative breast cancerYesol Kim, Je Yeong Ko, Soo-Been Lee, et al.
Annals of Surgical Oncology|March 27, 2013
Clinical usefulness of AJCC response criteria for neoadjuvant chemotherapy in breast cancerBhumsuk Keam, Seock-Ah Im, Yoojoo Lim, et al.
Breast Cancer Research and Treatment|October 18, 2007
CASP8 polymorphisms, estrogen and progesterone receptor status, and breast cancer riskSohee Han, Kyoung-Mu Lee, Ji-Yeob Choi, et al.
Breast Cancer Research and Treatment|June 23, 2016
Loss of ataxia-telangiectasia-mutated protein expression correlates with poor prognosis but benefits from anthracycline-containing adjuvant chemotherapy in breast cancerKoung Jin Suh, Han Suk Ryu, Kyung-Hun Lee, et al.
Annals of Surgical Oncology|June 6, 2008
A scoring system to predict nonsentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a comparison with other scoring systemsJihyoung Cho, Wonshik Han, Jong Won Lee, et al.
Pageof 39

Showing results (281-290 of 384) with videos related to

Sort By:
Pageof 39
Oncotarget|September 3, 2016
Accelerated whole breast irradiation in early breast cancer patients with adverse prognostic featuresSea-Won Lee, Kyung Hwan Shin, Eui Kyu Chie, et al.
Scientific Reports|April 20, 2021
Analysis of BRCA1/2 variants of unknown significance in the prospective Korean Hereditary Breast Cancer studyJoo Heung Kim, Sunggyun Park, Hyung Seok Park, et al.
Molecular Cancer Research : MCR|October 18, 2012
STAT3-RANTES autocrine signaling is essential for tamoxifen resistance in human breast cancer cellsEun Hee Yi, Chang Seok Lee, Jin-Ku Lee, et al.
BMC Cancer|April 14, 2007
Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapyKyung-Hun Lee, Seock-Ah Im, Do-Youn Oh, et al.
Journal of Breast Cancer|April 7, 2017
Genetic Predisposition of Polymorphisms in <i>HMGB1</i>-Related Genes to Breast Cancer Prognosis in Korean WomenJunsu Lee, Jaesung Choi, Seokang Chung, et al.
Oncogene|April 30, 2022
Reduced miR-371b-5p expression drives tumor progression via CSDE1/RAC1 regulation in triple-negative breast cancerYesol Kim, Je Yeong Ko, Soo-Been Lee, et al.
Annals of Surgical Oncology|March 27, 2013
Clinical usefulness of AJCC response criteria for neoadjuvant chemotherapy in breast cancerBhumsuk Keam, Seock-Ah Im, Yoojoo Lim, et al.
Breast Cancer Research and Treatment|October 18, 2007
CASP8 polymorphisms, estrogen and progesterone receptor status, and breast cancer riskSohee Han, Kyoung-Mu Lee, Ji-Yeob Choi, et al.
Breast Cancer Research and Treatment|June 23, 2016
Loss of ataxia-telangiectasia-mutated protein expression correlates with poor prognosis but benefits from anthracycline-containing adjuvant chemotherapy in breast cancerKoung Jin Suh, Han Suk Ryu, Kyung-Hun Lee, et al.
Annals of Surgical Oncology|June 6, 2008
A scoring system to predict nonsentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a comparison with other scoring systemsJihyoung Cho, Wonshik Han, Jong Won Lee, et al.
Pageof 39